Skip to content

Rh D Alloantibody Detection by Latex Agglutination (Blood Sample)

Published: August 9, 2026Updated: August 16, 2026

This test checks for the presence of antibodies against the RhD antigen in your blood, which can occur after blood transfusions, pregnancy, or certain blood disorders. It helps prevent complications like hemolytic disease of the fetus and newborn.

Quick summary

["Identifies RhD antibodies that may cause serious blood compatibility issues."]

Medically reviewed by WellAlly Editorial TeamLast reviewed August 16, 2026Editorial policy

Key facts at a glance

LOINC
35465-4
Short code
RHD allele Geno Bld/T
Synonyms
RHD allele Geno Bld/T
Category
chemistry
Sample
whole-blood
Container
Lavender-top (EDTA)
Units
N/A
Fasting
false
Population
adult
Sex
all
Age range
18–65 years
Method
molgen
Specimen volume
3 mL
Stability
Room temperature: 4h, Refrigerated: 24h
Hemolysis max
0
Lipemia max
0
Icterus max
0
TAT
4–24 hours
Order
routine

Why This Test Matters for Blood Safety

Your healthcare provider may order this test if you’ve had a blood transfusion, are pregnant, or have a history of red blood cell problems. It ensures your blood is compatible for future transfusions or pregnancy care.

How the Test Works

A small sample of your blood is mixed with RhD-coated latex particles. If antibodies are present, they bind to the particles, causing them to clump. This clumping is detected visually or through a machine.

What to Expect Before the Test

No special preparation is needed. You may have a small needle inserted into your arm to draw blood, similar to other routine blood tests. The process usually takes a few minutes.

Possible Results and Next Steps

A positive result means antibodies are detected. Your doctor will discuss next steps, which may include further testing or adjustments to your treatment plan, such as avoiding certain blood products.

Clinical interpretation

How abnormal results are interpreted and what conditions they suggest.

RhD antibodies can lead to severe reactions if exposed to RhD-positive blood during transfusions or during pregnancy, potentially causing anemia or other complications in the fetus. This test is critical for managing patients with blood disorders, those who’ve had transfusions, or those who are pregnant to ensure safe blood compatibility.

Short name

RhD Antibody Screen (Serum/Plasma)

Frequently asked questions

What does a positive result mean?
A positive result indicates the presence of RhD antibodies in your blood. This may require further evaluation by your healthcare provider to determine the best course of action, such as additional testing or precautions during blood transfusions or pregnancy.
Can I avoid this test if I’ve never had a transfusion or pregnancy?
Not necessarily. Some people are screened routinely, especially if they have conditions like autoimmune diseases or are at higher risk for blood incompatibility. Your doctor will decide if this test is needed for your specific situation.
How often should I get this test?
Frequency depends on your medical history and current health status. Your doctor will advise you based on your needs, such as after a transfusion, during pregnancy, or if you have a history of blood-related issues.
  1. 1
  2. 2
  3. 3

Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy